Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients
Authors:
- 1 May 2007
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 20 (5) , 419-424
Abstract
Cytomegalovirus (CMV) infection causes significant morbidity and mortality among transplant recipients. Although it is still not clear if a preemptive strategy is superior to a prophylactic strategy, many transplant programs elect for preemptive treatment for post-transplant CMV infection. In order to improve the preemptive strategy, we analyzed a series of liver recipients by means of quantitative real-time polymerase chain reaction (PCR). Ninety-one liver transplant recipients were monitored by real-time PCR for CMV, and the results were analyzed in terms of preoperative conditions. Multivariate analysis revealed fulminant hepatic failure as an underlying disease (odds ratio, 6.8; 95% CI, 1.2-39.2), while an ABO-incompatible graft (odds ratio, 5.0; 95% CI, 1.3-19.1), and a serological combination of the donor (D) being positive with the recipient (R) being negative for CMV (D+/R-) (odds ratio, 5.8; 95% CI, 1.3-26.0) were independently associated with the development of significant CMV infection. Patients with risk factors had higher peak CMV DNA concentrations than those without, and developed CMV infections faster (P = 0.0002). Screening of recipients according to risk factors and PCR monitoring may result in an optimization of the preemptive strategy.Keywords
This publication has 25 references indexed in Scilit:
- Pre-emptive Treatment for Cytomegalovirus Viremia to Prevent Cytomegalovirus Disease in Solid Organ Transplant RecipientsTransplantation, 2006
- Real-Time PCR Assay Compared to Nested PCR and Antigenemia Assays for Detecting Cytomegalovirus Reactivation in Adult T-Cell Leukemia-Lymphoma PatientsJournal of Clinical Microbiology, 2003
- Monitoring of Cytomegalovirus Infection in Solid-Organ Transplant Recipients by an Ultrasensitive Plasma PCR AssayJournal of Clinical Microbiology, 2003
- CMV hepatitis after liver transplantation: Incidence, clinical course, and long-term follow-upLiver Transplantation, 2002
- Preemptive Strategy for Ganciclovir Administration Against Cytomegalovirus in Liver Transplantation RecipientsAmerican Journal of Transplantation, 2002
- Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCRJournal of Clinical Microbiology, 2001
- Cytomegalovirus infection of liver transplant recipients: Comparison of antigenemia and molecular biology assaysLiver Transplantation, 2001
- Prevention of Cytomegalovirus Disease in Recipients of Solid-Organ TransplantsClinical Infectious Diseases, 2001
- Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysisJournal of Hepatology, 1993
- DIRECT DETECTION OF CYTOMEGALOVIRUS IN PERIPHERAL BLOOD LEUKOCYTES-A REVIEW OF THE ANTIGENEMIA ASSAY AND POLYMERASE CHAIN REACTIONTransplantation, 1992